Status:
UNKNOWN
Project CORE: Disseminating Eating Disorders Treatment
Lead Sponsor:
The Miriam Hospital
Conditions:
Anorexia Nervosa/Bulimia
Anorexia Nervosa Restricting Type
Eligibility:
All Genders
12-18 years
Phase:
PHASE1
Brief Summary
The goals of this project are to 1) develop training opportunities for master's-level and pre-doctoral psychology students in evidence-based assessment and treatment of adolescent EDs; 2) to provide t...
Detailed Description
The complete project will incorporate three phases. Phase I is designed to gather information from existing licensed health professionals in the community who serve Medicaid populations on their knowl...
Eligibility Criteria
Inclusion
- Inclusion criteria include:
- meets criteria for AN, atypical AN, or BN according to DSM-5 diagnostic criteria
- is currently living at home
- is medically stable for outpatient treatment according to the recommended thresholds of the American Academy of Pediatrics and the Society of Adolescent Medicine (e.g., ≥75% of expected body weight, heartrate ≥50 beats per minute)
- if on a psychotropic medication, meets all eligibility criteria while on stable dose of psychotropic medication (8 weeks) for a co-morbid condition
- speaks English
- be available for long-term follow-up.
- Exclusion criteria include:
- associated physical illness that necessitates hospitalization
- psychotic illness/other mental illness requiring hospitalization
- current dependence on drugs or alcohol
- physical conditions (e.g. diabetes mellitus, pregnancy) known to influence eating or weight
- concurrent involvement in other psychological treatment for an eating disorder
- developmental delay that would preclude participation in the intervention.
Exclusion
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03855553
Start Date
January 1 2019
End Date
January 1 2022
Last Update
February 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Weight Control & Diabetes Research Center
Providence, Rhode Island, United States, 02903